<DOC>
	<DOCNO>NCT00718237</DOCNO>
	<brief_summary>The purpose study evaluate whether V260 effective well tolerate Japanese healthy infant .</brief_summary>
	<brief_title>Phase III Placebo-controlled Study V260 ( RotaTeqâ„¢ ) Japanese Healthy Infants ( V260-029 ) ( COMPLETED )</brief_title>
	<detailed_description />
	<mesh_term>Gastroenteritis</mesh_term>
	<criteria>Healthy Japanese Infants , 6 Weeks Through 12 Weeks Of Age History Of Known Prior Rotavirus Gastroenteritis Subjects Who Are Concurrently Participating In Or Are Anticipated To Participate In Other Studies Of Investigational Products At Any Time During The Study Period</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>12 Weeks</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Gastroenteritis</keyword>
	<keyword>Rotavirus</keyword>
</DOC>